![](/img/cover-not-exists.png)
Comparative study of the immunogenicity and safety of Engerix-B administered at 0, 1, 2 and 12 months and Recombivax HB administered at 0, 1, and 6 months in healthy adults
Vinod K. Rustgi, Charles J. Schleupner, David S. KrauseVolume:
13
Year:
1995
Language:
english
Pages:
1669
DOI:
10.1016/0264-410x(95)00118-k
File:
PDF, 697 KB
english, 1995